Transforming drug delivery platform for bone cancer

Our Technology

We incorporate approved molecules that can kill tumors and easily attach to the bone mineral called Hydroxyapatite (HA). Additionally, we deliver a specific drug throughout the body that finds the tumor, attaches to it, and works right where it’s needed. This increases the efficacy of targeted drug delivery without causing side-effects in other tissues.

Current Research Areas

Controlled local delivery of various first-line anti-cancer agents to the right place at the right time.

Explore the interactions between anti-cancer agents and hydroxyapatite to screen for more HA binding drugs.

Explore intracellular delivery of anti-cancer agents by materials to boost its efficacy.